GHK-Cu and all peptides referenced are intended strictly for laboratory research use and are not approved for human consumption, diagnosis, treatment, or prevention of any disease
BPC-157 human data consists of three small studies totaling fewer than 30 participants
Preliminary research also suggests that NAD+ may play a role in supporting sirtuin activity proteins being studied for their involvement in healthy aging
AOD-9604 attempts to isolate fat-loss benefits without the hormonal complications
Engineered solely for preclinical investigations, each batch of AHK-Cu receives a comprehensive quality assessment and includes complete documentation, such as a Certificate of Analysis (COA), purity data, and structural verification
Malpractice litigation is intended to protect patients from negligence, although it may have unintended consequences on medical practice